Investing in Medical Innovation
Accuitive Medical Ventures is a venture capital firm with committed capital of $230 million. Our office is located in Atlanta, GA. We're a market driven firm looking for revolutionary medical device technology investment opportunities.
AMV Culture & values
We specialize in two distinct types of investments:
Venture financing for companies with outstanding technology and teams
Venture financing and management of technologies being developed within The Innovation Factory
Accuitive Medical Ventures has a strong relationship with The Innovation Factory (TIF), the successful medical technology serial operating team. TIF has started thirteen companies since 1999 and is based in Atlanta, GA. In conjunction with TIF, Accuitive Medical Ventures has the resources and experience to create long-term value for all medical technology stakeholders.
Accuitive has established relationships with some of the industry’s leading institutions to offer emerging companies and investors the opportunity to build unique new businesses and long-term shareholder value. Accuitive’s connections to some of the industry’s leading practitioners, thought leaders and venture capital firms enable us to add substantial value as investors and board members.
Who we work with:
With the ultimate goal of creating value for our Limited Partners, Accuitive Medical Ventures serves two distinct groups of people:
Passionate, successful teams with strong leadership we can invest in to move exciting technology forward.
creative individuals and groups who would benefit from the business and medical device experience that partnering with The Innovation Factory provides.
What we look for in a partner:
Regardless of whether you’re an entrepreneur looking for an investment in your company or an inventor looking to partner with The Innovation Factory, we look for:
Large Target Market
The device or technology must have the potential to serve a large addressable global market.
Strong Intellectual Property
The technology should be novel with robust intellectual property protection.
The technology should create a new treatment modality or represent a substantial improvement.
Compelling Business Model
The technology should have a business model that provides a sustainable advantage.
Clear Path to Market
The technology must have definable regulatory, clinical, and reimbursement (if applicable) paths.
Multiple Exit Opportunities
The technology must fit an area of strategic need for potential acquirers.